Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Nuclear Scintigraphy in Practice: Gastrointestinal Motility.

Solnes LB, Sheikhbahaei S, Ziessman HA.

AJR Am J Roentgenol. 2018 May 29:1-7. doi: 10.2214/AJR.18.19787. [Epub ahead of print]

PMID:
29812981
2.

Precision Radiology Residency Training: Special Distinction Tracks for Noninterpretative Professional Development.

Snyder E, Solnes L, Horton KM, Johnson PT.

Acad Radiol. 2018 Jun;25(6):714-718. doi: 10.1016/j.acra.2017.11.028.

PMID:
29751858
3.

SSTR-RADS Version 1.0 as a Reporting System for SSTR PET Imaging and Selection of Potential PRRT Candidates: A Proposed Standardization Framework.

Werner RA, Solnes LB, Javadi MS, Weich A, Gorin MA, Pienta KJ, Higuchi T, Buck AK, Pomper MG, Rowe SP, Lapa C.

J Nucl Med. 2018 Jul;59(7):1085-1091. doi: 10.2967/jnumed.117.206631. Epub 2018 Mar 23.

PMID:
29572257
4.

Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to Arms.

Salas Fragomeni RA, Amir T, Sheikhbahaei S, Harvey SC, Javadi MS, Solnes LB, Kiess AP, Allaf ME, Pomper MG, Gorin MA, Rowe SP.

J Nucl Med. 2018 Jun;59(6):871-877. doi: 10.2967/jnumed.117.203570. Epub 2018 Mar 15.

PMID:
29545375
5.

99mTc-sestamibi SPECT/CT for the characterization of renal masses: a pictorial guide.

Campbell SP, Tzortzakakis A, Javadi MS, Karlsson M, Solnes LB, Axelsson R, Allaf ME, Gorin MA, Rowe SP.

Br J Radiol. 2018 Apr;91(1084):20170526. doi: 10.1259/bjr.20170526. Epub 2018 Feb 27. Review.

PMID:
29271233
6.

Correction to: Molecular imaging of advanced thyroid cancer: iodinated radiotracers and beyond.

Santhanam P, Solnes LB, Rowe SP.

Med Oncol. 2017 Dec 12;35(1):10. doi: 10.1007/s12032-017-1063-6.

PMID:
29234902
7.

Use of quantitative SPECT/CT reconstruction in 99mTc-sestamibi imaging of patients with renal masses.

Jones KM, Solnes LB, Rowe SP, Gorin MA, Sheikhbahaei S, Fung G, Frey EC, Allaf ME, Du Y, Javadi MS.

Ann Nucl Med. 2018 Feb;32(2):87-93. doi: 10.1007/s12149-017-1222-z. Epub 2017 Dec 6.

PMID:
29214562
8.

Decreased occipital lobe metabolism by FDG-PET/CT: An anti-NMDA receptor encephalitis biomarker.

Probasco JC, Solnes L, Nalluri A, Cohen J, Jones KM, Zan E, Javadi MS, Venkatesan A.

Neurol Neuroimmunol Neuroinflamm. 2017 Nov 15;5(1):e413. doi: 10.1212/NXI.0000000000000413. eCollection 2018 Jan.

9.

THE RELATIONSHIP OF BRAFV600E MUTATION STATUS TO FDG PET/CT AVIDITY IN THYROID CANCER: A REVIEW AND META-ANALYSIS.

Santhanam P, Khthir R, Solnes LB, Ladenson PW.

Endocr Pract. 2018 Jan;24(1):21-26. doi: 10.4158/EP-2017-0080. Epub 2017 Nov 16.

PMID:
29144823
10.

Molecular imaging of advanced thyroid cancer: iodinated radiotracers and beyond.

Santhanam P, Solnes LB, Rowe SP.

Med Oncol. 2017 Oct 30;34(12):189. doi: 10.1007/s12032-017-1051-x. Review. Erratum in: Med Oncol. 2017 Dec 12;35(1):10.

PMID:
29086115
11.

Unilateral Submandibular Gland Atrophy and Sialolithiasis Diagnosed on 99mTc-MIBI SPECT/CT in a Patient With Primary Hyperparathyroidism.

Pattanayak P, Santhanam P, Javadi MS, Solnes LB, Rowe SP.

Clin Nucl Med. 2017 Dec;42(12):939-940. doi: 10.1097/RLU.0000000000001863.

PMID:
29036000
12.

Appearance of Adrenal Myelolipomas on 2-deoxy-2-(18F) fluoro-D-glucose Positron Emission Tomography-Computed Tomography.

Rowe SP, Javadi MS, Solnes LB, Fishman EK.

World J Nucl Med. 2017 Oct-Dec;16(4):271-274. doi: 10.4103/1450-1147.215499.

13.

Correlation of 99mTc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expression.

Rowe SP, Gorin MA, Solnes LB, Ball MW, Choudhary A, Pierorazio PM, Epstein JI, Javadi MS, Allaf ME, Baras AS.

EJNMMI Res. 2017 Oct 2;7(1):80. doi: 10.1186/s13550-017-0329-5.

14.

ACR-ACNM Practice Parameter for the Performance of Dopamine Transporter (DaT) Single Photon Emission Computed Tomography (SPECT) Imaging for Movement Disorders.

Subramaniam RM, Frey KA, Hunt CH, Mercier GA Jr, Solnes LB, Colletti PM, Lu Y, Savir-Baruch B, Williams HT.

Clin Nucl Med. 2017 Nov;42(11):847-852. doi: 10.1097/RLU.0000000000001815.

PMID:
28922189
15.

Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted 18F-DCFPyL in peripheral ganglia.

Werner RA, Sheikhbahaei S, Jones KM, Javadi MS, Solnes LB, Ross AE, Allaf ME, Pienta KJ, Lapa C, Buck AK, Higuchi T, Pomper MG, Gorin MA, Rowe SP.

Ann Nucl Med. 2017 Nov;31(9):696-702. doi: 10.1007/s12149-017-1201-4. Epub 2017 Aug 22.

16.

Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging.

Sheikhbahaei S, Afshar-Oromieh A, Eiber M, Solnes LB, Javadi MS, Ross AE, Pienta KJ, Allaf ME, Haberkorn U, Pomper MG, Gorin MA, Rowe SP.

Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2117-2136. doi: 10.1007/s00259-017-3780-7. Epub 2017 Aug 1. Review.

PMID:
28765998
17.

Prostate-Specific Membrane Antigen-Targeted Imaging With [18F]DCFPyL in High-Grade Gliomas.

Salas Fragomeni RA, Menke JR, Holdhoff M, Ferrigno C, Laterra JJ, Solnes LB, Javadi MS, Szabo Z, Pomper MG, Rowe SP.

Clin Nucl Med. 2017 Oct;42(10):e433-e435. doi: 10.1097/RLU.0000000000001769.

18.

Prostate Specific Membrane Antigen Targeted 18F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center Study.

Gorin MA, Rowe SP, Patel HD, Vidal I, Mana-Ay M, Javadi MS, Solnes LB, Ross AE, Schaeffer EM, Bivalacqua TJ, Partin AW, Pienta KJ, Szabo Z, De Marzo AM, Pomper MG, Allaf ME.

J Urol. 2018 Jan;199(1):126-132. doi: 10.1016/j.juro.2017.07.070. Epub 2017 Jul 20.

19.

Reproductive history and fracture risk in postmenopausal women in a US national survey.

Santhanam P, Rowe SP, Solnes LB.

J Fam Plann Reprod Health Care. 2017 Jul;43(3):242-243. doi: 10.1136/jfprhc-2017-101808. No abstract available.

PMID:
28676547
20.

Incidental pulmonary arterial dilatation and coronary calcifications in patients with hypertension and normal findings on myocardial perfusion technetium-99m sestamibi single-photon emission computed tomography.

Santhanam P, Marcus C, Solnes LB, Kral BG, Javadi MS, Rowe SP.

J Clin Hypertens (Greenwich). 2017 Oct;19(10):1054-1055. doi: 10.1111/jch.13043. Epub 2017 Jun 23. No abstract available.

21.

Anti-DPPX encephalitis: prominent nystagmus reflected by extraocular muscle FDG-PET avidity.

Doherty L, Gold D, Solnes L, Probasco J, Venkatesan A.

Neurol Neuroimmunol Neuroinflamm. 2017 Jun 5;4(4):e361. doi: 10.1212/NXI.0000000000000361. eCollection 2017 Jul. No abstract available.

22.

Abnormal brain metabolism on FDG-PET/CT is a common early finding in autoimmune encephalitis.

Probasco JC, Solnes L, Nalluri A, Cohen J, Jones KM, Zan E, Javadi MS, Venkatesan A.

Neurol Neuroimmunol Neuroinflamm. 2017 May 11;4(4):e352. doi: 10.1212/NXI.0000000000000352. eCollection 2017 Jul.

23.

Pulmonary Perfusion Changes Following Extracardiac Lateral Fontan and Bilateral Bidirectional Glenn Shunt in Hypoplastic Right Ventricle With Duplicated Superior Vena Cava.

Salas Fragomeni RA, Turkbey EB, Jones BC, Solnes LB, Rowe SP.

Clin Nucl Med. 2017 May;42(5):377-378. doi: 10.1097/RLU.0000000000001605.

PMID:
28240666
24.

Pulmonary Perfusion Changes Following Single-Lung Transplantation.

Tsai J, Rowe SP, Solnes LB, Salas Fragomeni RA.

Clin Nucl Med. 2017 May;42(5):375-376. doi: 10.1097/RLU.0000000000001581.

PMID:
28221190
25.

Diagnostic Value of 18F-FDG PET/CT Versus MRI in the Setting of Antibody-Specific Autoimmune Encephalitis.

Solnes LB, Jones KM, Rowe SP, Pattanayak P, Nalluri A, Venkatesan A, Probasco JC, Javadi MS.

J Nucl Med. 2017 Aug;58(8):1307-1313. doi: 10.2967/jnumed.116.184333. Epub 2017 Feb 16.

PMID:
28209905
26.

Value of Intratumoral Metabolic Heterogeneity and Quantitative 18F-FDG PET/CT Parameters to Predict Prognosis in Patients With HPV-Positive Primary Oropharyngeal Squamous Cell Carcinoma.

Mena E, Taghipour M, Sheikhbahaei S, Jha AK, Rahmim A, Solnes L, Subramaniam RM.

Clin Nucl Med. 2017 May;42(5):e227-e234. doi: 10.1097/RLU.0000000000001578.

27.

Utility of I-124 PET/CT in identifying radioiodine avid lesions in differentiated thyroid cancer: a systematic review and meta-analysis.

Santhanam P, Taieb D, Solnes L, Marashdeh W, Ladenson PW.

Clin Endocrinol (Oxf). 2017 May;86(5):645-651. doi: 10.1111/cen.13306. Epub 2017 Feb 28. Review.

PMID:
28160320
28.

Functional Imaging of Evaluation of Diabetic Gastroparesis.

Santhanam P, Marashdeh W, Solnes L.

Curr Diabetes Rev. 2018;14(3):222-226. doi: 10.2174/1573399813666170126110932.

PMID:
28128051
29.

Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal Masses.

Sheikhbahaei S, Jones CS, Porter KK, Rowe SP, Gorin MA, Baras AS, Pierorazio PM, Ball MW, Higuchi T, Johnson PT, Solnes LB, Epstein JI, Allaf ME, Javadi MS.

Clin Nucl Med. 2017 Apr;42(4):e188-e193. doi: 10.1097/RLU.0000000000001534.

PMID:
28114223
30.

Myocardial Blood Flow and Inflammatory Cardiac Sarcoidosis.

Kruse MJ, Kovell L, Kasper EK, Pomper MG, Moller DR, Solnes L, Chen ES, Schindler TH.

JACC Cardiovasc Imaging. 2017 Feb;10(2):157-167. doi: 10.1016/j.jcmg.2016.09.023. Epub 2017 Jan 18.

31.

Plasma Fluoride Level and Femoral Bone Mineral Density in Post-Menopausal Women.

Santhanam P, Rowe SP, Solnes LB, Javadi MS.

Int J Occup Environ Med. 2017 Jan;8(1):56-57. doi: 10.15171/ijoem.2017.978. No abstract available.

32.

Whole-Body 18F-FDG PET and 18F-FDG PET/CT in Patients with Suspected Paraneoplastic Syndrome: A Systematic Review and Meta-Analysis of Diagnostic Accuracy.

Sheikhbahaei S, Marcus CV, Fragomeni RS, Rowe SP, Javadi MS, Solnes LB.

J Nucl Med. 2017 Jul;58(7):1031-1036. doi: 10.2967/jnumed.116.183905. Epub 2016 Dec 15. Review.

33.

Paraneoplastic Syndrome With Anti-NMDAR Encephalitis Associated With Ovarian Teratomas.

Pattanayak P, Solnes LB.

Clin Nucl Med. 2017 Feb;42(2):e128-e129. doi: 10.1097/RLU.0000000000001471.

PMID:
27941376
34.

Molecular Imaging and Precision Medicine: PET/Computed Tomography and Therapy Response Assessment in Oncology.

Sheikhbahaei S, Mena E, Pattanayak P, Taghipour M, Solnes LB, Subramaniam RM.

PET Clin. 2017 Jan;12(1):105-118. doi: 10.1016/j.cpet.2016.08.002. Epub 2016 Oct 5. Review.

PMID:
27863562
35.

Clinical Indications and Impact on Management: Fourth and Subsequent Posttherapy Follow-up 18F-FDG PET/CT Scans in Oncology Patients.

Taghipour M, Marcus C, Sheikhbahaei S, Mena E, Prasad S, Jha AK, Solnes L, Subramaniam RM.

J Nucl Med. 2017 May;58(5):737-743. doi: 10.2967/jnumed.116.183111. Epub 2016 Nov 3.

36.

18F-FDG PET/CT Imaging of Cauda Equina Syndrome Secondary to Leptomeningeal Metastatic Breast Cancer.

Solnes LB, Javadi MS, Rowe SP.

Clin Nucl Med. 2016 Nov;41(11):e485-e486.

PMID:
27607169
37.

The Value of FDG PET/CT in Treatment Response Assessment, Follow-Up, and Surveillance of Lung Cancer.

Sheikhbahaei S, Mena E, Yanamadala A, Reddy S, Solnes LB, Wachsmann J, Subramaniam RM.

AJR Am J Roentgenol. 2017 Feb;208(2):420-433. doi: 10.2214/AJR.16.16532. Epub 2016 Oct 11. Review.

PMID:
27726427
38.

PET-measured longitudinal flow gradient correlates with invasive fractional flow reserve in CAD patients.

Valenta I, Antoniou A, Marashdeh W, Leucker T, Kasper E, Jones SR, Dannals RF, Solnes L, Pomper MG, Schindler TH.

Eur Heart J Cardiovasc Imaging. 2017 May 1;18(5):538-548. doi: 10.1093/ehjci/jew116.

PMID:
27325812
39.

Use of 18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography for Patient Management and Outcome in Oropharyngeal Squamous Cell Carcinoma: A Review.

Taghipour M, Sheikhbahaei S, Marashdeh W, Solnes L, Kiess A, Subramaniam RM.

JAMA Otolaryngol Head Neck Surg. 2016 Jan;142(1):79-85. doi: 10.1001/jamaoto.2015.2607. Review.

PMID:
26583955
40.

Prospective Evaluation of (99m)Tc-sestamibi SPECT/CT for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors.

Gorin MA, Rowe SP, Baras AS, Solnes LB, Ball MW, Pierorazio PM, Pavlovich CP, Epstein JI, Javadi MS, Allaf ME.

Eur Urol. 2016 Mar;69(3):413-6. doi: 10.1016/j.eururo.2015.08.056. Epub 2015 Sep 18.

PMID:
26386607
41.

ADIPOSITY-RELATED CANCER AND FUNCTIONAL IMAGING OF BROWN ADIPOSE TISSUE.

Santhanam P, Solnes L, Hannukainen JC, Taïeb D.

Endocr Pract. 2015 Nov;21(11):1282-90. doi: 10.4158/EP15870.RA. Epub 2015 Aug 17. Review.

PMID:
26280202
42.

Contemporary approaches for imaging skeletal metastasis.

Ulmert D, Solnes L, Thorek DLj.

Bone Res. 2015 Jul 14;3:15024. doi: 10.1038/boneres.2015.24. eCollection 2015. Review.

43.

(18)F-Flourodeoxy-Glucose PET/Computed Tomography in Brain Tumors: Value to Patient Management and Survival Outcomes.

Wray R, Solnes L, Mena E, Meoded A, Subramaniam RM.

PET Clin. 2015 Jul;10(3):423-30. doi: 10.1016/j.cpet.2015.03.011. Review.

PMID:
26099676
44.

FDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer's Disease.

Murray J, Tsui WH, Li Y, McHugh P, Williams S, Cummings M, Pirraglia E, Solnes L, Osorio R, Glodzik L, Vallabhajosula S, Drzezga A, Minoshima S, de Leon MJ, Mosconi L.

Adv J Mol Imaging. 2014 Apr;4(2):15-26.

45.

99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen: pharmacokinetics and biodistribution studies in healthy subjects and patients with metastatic prostate cancer.

Vallabhajosula S, Nikolopoulou A, Babich JW, Osborne JR, Tagawa ST, Lipai I, Solnes L, Maresca KP, Armor T, Joyal JL, Crummet R, Stubbs JB, Goldsmith SJ.

J Nucl Med. 2014 Nov;55(11):1791-8. doi: 10.2967/jnumed.114.140426. Epub 2014 Oct 23.

46.

Neuroimaging markers of motor and nonmotor features of Parkinson's disease: an 18f fluorodeoxyglucose positron emission computed tomography study.

Huang C, Ravdin LD, Nirenberg MJ, Piboolnurak P, Severt L, Maniscalco JS, Solnes L, Dorfman BJ, Henchcliffe C.

Dement Geriatr Cogn Disord. 2013;35(3-4):183-96. doi: 10.1159/000345987. Epub 2013 Feb 22.

PMID:
23445555
47.

A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: what is new?

Vallabhajosula S, Solnes L, Vallabhajosula B.

Semin Nucl Med. 2011 Jul;41(4):246-64. doi: 10.1053/j.semnuclmed.2011.02.003. Review.

PMID:
21624560

Supplemental Content

Loading ...
Support Center